Brief: Immuneonco Biopharmaceuticals Shanghai Announces License And Collaboration Agreement
Aug 1 (Reuters) - ImmuneOnco Biopharmaceuticals Shanghai
Inc 1541.HK :
* LICENSE AND COLLABORATION AGREEMENT WITH SYNBIOTX FOR
IMM2510
AND IMM27M
* UNDER DEAL, CO TO RECEIVE UPFRONT & POTENTIAL NEAR-TERM
PAYMENTS
OF UP TO $50 MILLION
Further company coverage: 1541.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ImmuneOnco Biopharmaceuticals (Shanghai)
See all newsBrief: Immuneonco Biopharmaceuticals (Shanghai) To Subscribe For Wealth Management Product For Hk$87.5 Million
Brief: ImmuneOnCo Biopharmaceuticals (Shanghai) To Repurchase H Shares In Open Market
Brief: Immuneonco Biopharmaceuticals (Shanghai)Subscribes For Hk$212 Million Wealth Management Product
Brief: Immuneonco Biopharmaceuticals Shanghai Inc Posts FY Loss Attributable RMB218.6 Million
Brief: ImmuneOnco Biopharmaceuticals Shanghai Receives Approval From NMPA China For Investigational New Drug Application Of IMM0306S